Emmaus Life Sciences, Inc. (OTCMKTS:EMMA – Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 700 shares, a decline of 12.5% from the March 31st total of 800 shares. Based on an average daily volume of 800 shares, the days-to-cover ratio is currently 0.9 days.
Emmaus Life Sciences Stock Performance
Shares of Emmaus Life Sciences stock remained flat at $0.10 during trading on Tuesday. The company has a market cap of $6.19 million, a P/E ratio of -1.00 and a beta of 1.61. Emmaus Life Sciences has a 1 year low of $0.05 and a 1 year high of $0.34. The firm’s 50-day moving average price is $0.11 and its 200-day moving average price is $0.11.
Emmaus Life Sciences Company Profile
Further Reading
- Five stocks we like better than Emmaus Life Sciences
- What Are Dividends? Buy the Best Dividend Stocks
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- ETF Screener: Uses and Step-by-Step Guide
- Hilton Demonstrates Asset Light is Right for Investors
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Emmaus Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emmaus Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.